Skip to main content

Innovations in Immunity

inSIGHT™ T Cell diagnostic delivers a deeper understanding of patients' response to viral antigens

  • Assess current immune response for viral target

  • Confirm if virus specific CD4 and CD8 T Cells are present

  • Evaluate treatment decisions

Learn more about Eurofins Viracor inSIGHT™ for examining T cell response:

It's your job to keep patients safe; our job is to help you do it.

The Advantages of inSIGHT™

With inSIGHT™, you're now armed with the data to help answer critical questions: Is the patient's body producing a T Cell response? Is that response strong enough to make treatment adjustments? Are they ready to discontinue antiviral medication? Did their body respond to the vaccine?

For Clinical Staff

  • Reports CD4 and CD8 responses separately
  • Provides numerical values for various reportables
  • Ability for result consultation with scientific liaisons

For Lab Staff

  • Does not require additional staff or training
  • Live cell ambient shippers available
  • Simple blood draw, no extra processing to isolate PBMC

Gain inSIGHT into an Immunocompromised Patient's T Cell Immune Response featuring: CMV and SARS-CoV-2

Dr. Nirav Raval
Medical Director of Thoracic Transplant, Transplant Cardiologist
Advent Health
Dr. Fareed Khawaja
Assistant Professor, Department of Infectious diseases, Infection Control and Employee Health
University of Texas MD Anderson Cancer Center
Dr. Steve Kleiboeker
Vice President of Research and Development
Eurofins US Clinical Diagnostics

Join Dr.'s Raval, Khawaja and Kleiboeker to learn more about virus-specific T cell immunity for CMV and SARS-CoV-2. Dr. Raval, a board-certified Cardiologist, will share his experience utilizing the CMV T Cell Immunity panel in heart transplant patients. Dr. Khawaja, an Infectious Disease physician, will present his experience with CMV cellular immunity in hematopoietic cell transplant recipients with low level viremia. Finally, Dr. Kleiboeker will describe the new SARS-CoV-2 inSIGHT T Cell Immunity test as well as discuss future T Cell Immunity testing innovations to come.

Oral Abstract Special Presentation from ATC 2021:

"Detection of SARS-CoV-2 Specific Functional T Cell Using a Seven Color Flow Cytometry Assay"

Listen to Eurofins Viracor's Senior Scientist, Dr. Linda Flebbe-Rehwaldt, describe the methodology and results of this innovative immunity test. WATCH NOW


T Cell Immunity Testing - Flow Cytometry

How It Works

inSIGHT™ utilizes intracellular cytokine staining analyzed by flow cytometry to measure the strength of T cell responses to viral specific antigens or proteins. It evaluates and reports the activity of CD4 and CD8 T Cell responses separately.


Results Reporting

… Unlike ELISpot or QuantiFERONassays, ICS can thus provide both quantitative and qualitative characteristics of CMV-specific T cells.”

Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. Apr 15 2010;89(7):779-95.


Evaluating Cytomegalovirus Cell Mediated Immunity Diagnostic Assays

Explore data on various CMV cell mediated immunity assays and how they can potentially benefit your immunocompromised patients.

Back to top